Newsroom

October 22, 2019
Covetrus Announces CEO and Chairman Transition
Benjamin Shaw steps down as CEO and president and will serve as a strategic advisor to the board of Covetrus . Board chair Wolin to assume role as acting CEO and president, lead independent director Laskawy to serve as board chair. PORTLAND, Maine --(BUSINESS WIRE)--Oct.
October 1, 2019
Covetrus Announces Enhanced Partnership with Veterinary Study Groups, Inc.
  VSG selects Covetrus as a Preferred Partner for prescription management and specialty pharmacy     PORTLAND, Maine --(BUSINESS WIRE)--Oct. 1, 2019-- Covetrus  (NASDAQ: CVET), a global leader in animal-health technology and services, announced a newly expanded strategic partnership with Veterinary
September 23, 2019
Covetrus Appoints Dustin K. Finer as Chief People Officer
  Veteran HR and operations executive with experience supporting global organizations through transformation joins Covetrus executive leadership team     PORTLAND, Maine --(BUSINESS WIRE)--Sep. 23, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today
September 4, 2019
Covetrus Announces Board Chair Succession
Independent Director Benjamin Wolin Assumes Board Chair Role PORTLAND, Maine --(BUSINESS WIRE)--Sep. 4, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Benjamin Wolin as chair of its board of directors effective September
August 13, 2019
Covetrus Announces Financial Results for Second Quarter of 2019
Net sales of $1,009 million , relatively flat year-over-year, non-GAAP pro forma organic net sales declined 1% year-over-year In North America , net sales of $552 million , or a 6% increase year-over-year; prescription management platform net sales growth of 46% year-over-year and 22% sequentially;